No Validated Epithalon Age-Reversal Test Commercial testing before and after Epithalon exposure cannot establish rejuvenation unless the test is validated, the change exceeds normal variation and a controlled comparator is included
Incidence rates for stroke, MI, and their composite were 4.91, 3.81, and 8.42 per 1000 person-years lower, respectively, in the OW GLP-1 RA group compared with the DPP-4i group
doi: 10.1007/s12020-021-02718-w 93 da RochaAFPereira JuniorPSCalefiGSMarquezineGFMorimotoHKMazzucoTLet al
Use an Ozempic Lawsuit Claim When: You used Ozempic, Wegovy, or another GLP-1 drug for at least 30 days You were diagnosed with gastroparesis, intestinal obstruction, or severe GI conditions after starting the drug Your diagnosis was confirmed by a physician with documented medical records Your injury required hospitalization, surgery, or ongoing medical treatment You were not adequately warned by your physician or the drug's labeling of the specific risks involved Do Not Expect to Qualify If: Your only symptoms were the mild nausea described as expected in the drug's labeling You stopped the drug voluntarily with no lasting injury You have no medical documentation of your diagnosis or treatment Your statute of limitations has already expired (consult an attorney immediately to verify) The injuries you experienced are not supported by existing medical and scientific literature related to GLP-1 drugs Situation: A patient in her mid-40s was prescribed Ozempic off-label for weight loss by her primary care physician in early 2023
A controlled trial to determine the efficacy of red and near-infrared light treatment in patient satisfaction, reduction of fine lines, wrinkles, skin roughness, and intradermal collagen density increase
Always carry Wegovy in an insulated cooling case in your hand luggage
